NCT00147485View on ClinicalTrials.gov

A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
NeoplasmsLymphoma, Non-Hodgkin
Interventions
DRUG

AG-024322

Trial Locations (4)

19104

Pfizer Investigational Site, Philadelphia

02114

Pfizer Investigational Site, Boston

02115

Pfizer Investigational Site, Boston

02215

Pfizer Investigational Site, Boston

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY